{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:20:19Z","timestamp":1785345619652,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.intimp.2025.114291","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:30:27Z","timestamp":1739856627000},"page":"114291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII\/CaN signal transduction in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"150","author":[{"given":"Qian-qian","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-zhou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-yan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-biao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ting","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik Nur Syazni Nik Mohamed","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuanghao","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114291_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9 edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.intimp.2025.114291_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.intimp.2025.114291_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819834869","article-title":"Diabetic cardiomyopathy: prevalence, determinants and potential treatments","volume":"10","author":"Gulsin","year":"2019","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.intimp.2025.114291_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112833","article-title":"Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy","volume":"20","author":"Zamora","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.114291_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1479164118787415","article-title":"The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis","volume":"15","author":"Bouthoorn","year":"2018","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.114291_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00592-013-0455-0","article-title":"Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study","volume":"50","author":"Konduracka","year":"2013","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114291_bb0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.intimp.2025.114291_bb0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2025.114291_bb0045","article-title":"Pyroptosis and its regulation in diabetic cardiomyopathy","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.114291_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107920","article-title":"Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy","volume":"228","author":"Dannenberg","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2025.114291_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.intimp.2025.114291_bb0060","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114291_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110008","article-title":"Cardioprotective role of A-cycloglycosylated derivative of Rubiadin in diabetic cardiomyopathy in rats","volume":"118","author":"Zhu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114291_bb0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCRESAHA.107.160176","article-title":"Role of TRPM2 channel in mediating H2O2-induced Ca2+ entry and endothelial hyperpermeability","volume":"102","author":"Hecquet","year":"2008","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.intimp.2025.114291_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147635","article-title":"The role of TRPM2 in endothelial function and dysfunction","volume":"22","author":"Zieli\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114291_bb0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.bjp.0705914","article-title":"TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase","volume":"143","author":"Fonfria","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114291_bb0085","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00018-010-0533-1","article-title":"Poly(ADP-ribose)glycohydrolase is an upstream regulator of Ca2+ fluxes in oxidative cell death","volume":"68","author":"Blenn","year":"2011","journal-title":"Cellular and molecular life sciences\u202f: CMLS"},{"issue":"8","key":"10.1016\/j.intimp.2025.114291_bb0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/micc.12158","article-title":"Oxidative Stress Increases Pulmonary Vascular Permeability in Diabetic Rats through Activation of Transient Receptor Potential Melastatin 2 Channels","volume":"21","author":"Lu","year":"2014","journal-title":"Microcirculation (New York, N.Y.\u202f: 1994)"},{"issue":"490","key":"10.1016\/j.intimp.2025.114291_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal4161","article-title":"High glucose-induced ROS activates TRPM2 to trigger lysosomal membrane permeabilization and Zn-mediated mitochondrial fission","volume":"10","author":"Abuarab","year":"2017","journal-title":"Sci. Signal."},{"issue":"9","key":"10.1016\/j.intimp.2025.114291_bb0100","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2025.114291_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lfs.2018.05.038","article-title":"Perilla aldehyde attenuates CUMS-induced depressive-like behaviors via regulating TXNIP\/TRX\/NLRP3 pathway in rats","volume":"206","author":"Song","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114291_bb0110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.fct.2016.11.023","article-title":"Phytochemical and phytopharmacological review of Perilla frutescens L. (Labiatae), a traditional edible-medicinal herb in China","volume":"108","author":"Yu","year":"2017","journal-title":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association"},{"key":"10.1016\/j.intimp.2025.114291_bb0115","article-title":"Perillaldehyde inhibits AHR signaling and activates NRF2 antioxidant pathway in human keratinocytes","volume":"2018","author":"Fuyuno","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.intimp.2025.114291_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1167\/iovs.61.6.51","article-title":"Perillaldehyde ameliorates aspergillus fumigatus keratitis by activating the Nrf2\/HO-1 signaling pathway and inhibiting Dectin-1-mediated inflammation","volume":"61","author":"Fan","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114291_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041518","article-title":"The molecular mechanism of Perillaldehyde inducing cell death in aspergillus flavus by inhibiting energy metabolism revealed by transcriptome sequencing","volume":"21","author":"Pan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.114291_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010032","article-title":"In vivo anti-tumor activity and toxicological evaluations of Perillaldehyde 8,9-epoxide, a derivative of Perillyl alcohol","volume":"17","author":"Andrade","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.114291_bb0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.pharep.2019.01.009","article-title":"Hippocampal BDNF signaling is required for the antidepressant effects of perillaldehyde","volume":"71","author":"Zhu","year":"2019","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2025.114291_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.phymed.2003.08.004","article-title":"Vasodilative effect of perillaldehyde on isolated rat aorta","volume":"12","author":"Takagi","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.114291_bb0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2016.02.003","article-title":"Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: formulation, in vitro and in vivo evaluation","volume":"85","author":"Omari-Siaw","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.114291_bb0150","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1002\/jcb.27362","article-title":"Perillaldehyde prevents the formations of atherosclerotic plaques through recoupling endothelial nitric oxide synthase","volume":"119","author":"Yu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.114291_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109274","article-title":"PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K\/AKT phosphorylation","volume":"113","author":"Yin","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114291_bb0160","article-title":"BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114291_bb0165","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114291_bb0170","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.intimp.2025.114291_bb0175","first-page":"2924","article-title":"DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks","volume":"26","author":"Bauer-Mehren","year":"2010","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.intimp.2025.114291_bb0180","doi-asserted-by":"crossref","unstructured":"J. Pi\u00f1ero, J. Ram\u00edrez-Anguita, J. Sa\u00fcch-Pitarch, F. Ronzano, E. Centeno, F. Sanz, L. Furlong, The DisGeNET knowledge platform for disease genomics: 2019 update, Nucleic Acids Res. 48 (2020) D845-D855.","DOI":"10.1093\/nar\/gkz1021"},{"key":"10.1016\/j.intimp.2025.114291_bb0185","doi-asserted-by":"crossref","first-page":"1.30.1","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.intimp.2025.114291_bb0190","doi-asserted-by":"crossref","unstructured":"B. Sherman, M. Hao, J. Qiu, X. Jiao, M. Baseler, H. Lane, T. Imamichi, W. Chang, DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update), Nucleic Acids Res. 50 (2022) W216-W221.","DOI":"10.1093\/nar\/gkac194"},{"key":"10.1016\/j.intimp.2025.114291_bb0195","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114291_bb0200","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB protein data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"Burley","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114291_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175836","article-title":"Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3\u03b2","volume":"953","author":"Yu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114291_bb0210","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2025.114291_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101747","article-title":"Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway","volume":"37","author":"Hu","year":"2020","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114291_bb0220","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","article-title":"CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats","volume":"60","author":"Ma","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.intimp.2025.114291_bb0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12012-018-9462-2","article-title":"Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors: mechanisms of action and role in cardiovascular disorders","volume":"18","author":"Henning","year":"2018","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.intimp.2025.114291_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/bs.apcsb.2020.12.001","article-title":"TRPM2 channel in oxidative stress-induced mitochondrial dysfunction and apoptotic cell death","volume":"125","author":"Malko","year":"2021","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114291_bb0235","first-page":"369","article-title":"Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure","volume":"17","author":"Pacher","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114291_bb0240","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yexcr.2018.10.003","article-title":"PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1\u03b1 axis","volume":"373","author":"Waldman","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"24","key":"10.1016\/j.intimp.2025.114291_bb0245","doi-asserted-by":"crossref","first-page":"35618","DOI":"10.18632\/oncotarget.8343","article-title":"Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.intimp.2025.114291_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2478\/enr-2021-0008","article-title":"Parp-1The and genes as potential targets for treatment of the heart functioning impairments induced by type 1 diabetes mellitus","volume":"55","author":"Kuchmerovska","year":"2021","journal-title":"Endocr. Regul."},{"issue":"1","key":"10.1016\/j.intimp.2025.114291_bb0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13020-021-00545-9","article-title":"Perillaldehyde improves cognitive function in vivo and in vitro by inhibiting neuronal damage via blocking TRPM2\/NMDAR pathway","volume":"16","author":"Qiu","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.intimp.2025.114291_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/srep35016","article-title":"TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells","volume":"6","author":"Tseng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114291_bb0265","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.yjmcc.2019.01.001","article-title":"CaMKII signaling in heart diseases: emerging role in diabetic cardiomyopathy","volume":"127","author":"Hegyi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114291_bb0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00424-021-02650-y","article-title":"Ca mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy","volume":"474","author":"Jaquenod De Giusti","year":"2022","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114291_bb0275","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00125-020-05103-w","article-title":"Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis","volume":"63","author":"Qi","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114291_bb0280","article-title":"Ameliorative potentials of the ethanolic extract from Lycium chinense leaf extract against diabetic cardiomyopathy. Insight into oxido-inflammatory and apoptosis modulation","volume":"154","author":"Chaoling","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114291_bb0285","article-title":"Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy","volume":"256","author":"Dan","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114291_bb0290","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8359013","article-title":"Effect of Astragalus polysaccharides on cardiac dysfunction in db\/db mice with respect to oxidant stress","volume":"2018","author":"Chen","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.intimp.2025.114291_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098044","article-title":"Flos Puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2025.114291_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030950","article-title":"Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes","volume":"vol. 27","author":"Singh","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.intimp.2025.114291_bb0305","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/jcb.22635","article-title":"Poly (ADP-ribose) polymerase-1 binds to BCL2 major breakpoint region and regulates BCL2 expression","volume":"110","author":"Yang","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"16","key":"10.1016\/j.intimp.2025.114291_bb0310","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1158\/0008-5472.CAN-11-4204","article-title":"BCL2 suppresses PARP1 function and nonapoptotic cell death","volume":"72","author":"Dutta","year":"2012","journal-title":"Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T04:14:26Z","timestamp":1763784866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":62,"alternative-id":["S1567576925002814"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114291","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perillaldehyde targeting PARP1 to inhibit TRPM2-CaMKII\/CaN signal transduction in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114291"}}